Copyright (c) 2016 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
One-Pot Three Component Synthesis of Highly Functionalized Novel 1,8-Naphthyridine Derivatives from Substituted 2-Aminopyridines, Aldehydes and Malononitrile
Corresponding Author(s) : Muhammad Yaqub
Asian Journal of Chemistry,
Vol. 28 No. 1 (2016): Vol 28 Issue 1
Abstract
Protocol for one-pot three component cascade synthesis was planned to achieve the highly functionalized novel 1,8-naphthyridine derivatives from readily available starting material. Substituted aldehydes and malononitrile were refluxed in THF followed by the addition of substituted 2-aminopyridine to obtain highly functionalized novel 1-8-naphthyridine (12a-12x), in good to excellent yields. The structures of the newly synthesized 1,8-naphthyridine derivatives have been established on the basis of analytical (C, H, N) and spectroscopic (1H NMR and 13C NMR) data. These fully functionalized heterocycles would be employed as versatile synthons for further chemical transformation and eventually, screened for biological studies.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- L.-R. Wen, C.-Y. Jiang, M. Li and L.-J. Wang, Tetrahedron, 67, 293 (2011); doi:10.1016/j.tet.2010.11.049.
- M.A. Seefeld, W.H. Miller, K.A. Newlander, W.J. Burgess, W.E. DeWolf, P.A. Elkins, M.S. Head, D.R. Jakas, C.A. Janson, P.M. Keller, P.J. Manley, T.D. Moore, D.J. Payne, S. Pearson, B.J. Polizzi, X. Qiu, S.F. Rittenhouse, I.N. Uzinskas, N.G. Wallis and W.F. Huffman, J. Med. Chem., 46, 1627 (2003); doi:10.1021/jm0204035.
- G. Grossi, M. Di Braccio, G. Roma, V. Ballabeni, M. Tognolini and E. Barocelli, Eur. J. Med. Chem., 40, 155 (2005); doi:10.1016/j.ejmech.2004.09.022.
- P.L. Ferrarini, C. Mori, V. Calderone, L. Calzolari, P. Nieri, G. Saccomanni and E. Martinotti, Eur. J. Med. Chem., 34, 505 (1999); doi:10.1016/S0223-5234(99)80099-3.
- S.K. Srivastava, M. Jaggi, A.T. Singh, A. Madan, N. Rani, M. Vishnoi, S.K. Agarwal, R. Mukherjee and A.C. Burman, Bioorg. Med. Chem. Lett., 17, 6660 (2007); doi:10.1016/j.bmcl.2007.08.006.
- D.C. Adelman, M.J. Evanchik, A. Sudhakar, J.W. Jacobs and J.A. Silverman, 1,8-Naphthyridine Compounds for the Treatment of Cancer, US Patent 8124773 B2 (2012).
- Y.J. Hwang. Chung, E.C. Nam, W.T. Kim, J.B. Youm and C.H. Leem, Korean J. Physiol. Pharmacol., 17, 537 (2013); doi:10.4196/kjpp.2013.17.6.537.
- G. Grover and S.G. Kini, Eur. J. Med. Chem., 41, 256 (2006); doi:10.1016/j.ejmech.2005.09.002.
- S.K. Bouchillon, D.J. Hoban, J.L. Johnson, B.M. Johnson, D.L. Butler, K.A. Saunders, L.A. Miller and J.A. Poupard, Int. J. Antimicrob. Agents, 23, 181 (2004); doi:10.1016/j.ijantimicag.2003.08.006.
- P.L. Ferrarini, C. Mori, M. Badawneh, V. Calderone, R. Greco, C. Manera, A. Martinelli, P. Nieri and G. Saccomanni, Eur. J. Med. Chem., 35, 815 (2000); doi:10.1016/S0223-5234(00)00173-2.
- A. Samadi, C. Valderas, C. Ríos, A. Bastida, M. Chioua, L. González-Lafuente, I. Colmena, L. Gandía, A. Romero, L. Barrio, M.D. Martín-de-Saavedra, M.G. López, M. Villarroya and J. Marco-Contelles, Bioorg. Med. Chem., 19, 122 (2011); doi:10.1016/j.bmc.2010.11.040.
- M. Fischer and A. Bacher, Adv. Bot. Res., 58, 93 (2011); doi:10.1016/B978-0-12-386479-6.00003-2.
- M. Yaqub, R. Perveen, Z. Shafiq, H. Pervez and M.N. Tahir, Synlett, 1755 (2012); doi:10.1055/s-0031-1289787.
- M. Yaqub, C.-Y. Yu, Y.-M. Jia and Z.-T. Huang, Synlett, 1357 (2008); doi:10.1055/s-2008-1072788.
- M. Yaqub, N. Arif, R. Perveen, J. Batool, M.T. Riaz and M. Yaseen, Asian J. Chem., 27, 1013 (2015); doi:10.14233/ajchem.2015.18004.
References
L.-R. Wen, C.-Y. Jiang, M. Li and L.-J. Wang, Tetrahedron, 67, 293 (2011); doi:10.1016/j.tet.2010.11.049.
M.A. Seefeld, W.H. Miller, K.A. Newlander, W.J. Burgess, W.E. DeWolf, P.A. Elkins, M.S. Head, D.R. Jakas, C.A. Janson, P.M. Keller, P.J. Manley, T.D. Moore, D.J. Payne, S. Pearson, B.J. Polizzi, X. Qiu, S.F. Rittenhouse, I.N. Uzinskas, N.G. Wallis and W.F. Huffman, J. Med. Chem., 46, 1627 (2003); doi:10.1021/jm0204035.
G. Grossi, M. Di Braccio, G. Roma, V. Ballabeni, M. Tognolini and E. Barocelli, Eur. J. Med. Chem., 40, 155 (2005); doi:10.1016/j.ejmech.2004.09.022.
P.L. Ferrarini, C. Mori, V. Calderone, L. Calzolari, P. Nieri, G. Saccomanni and E. Martinotti, Eur. J. Med. Chem., 34, 505 (1999); doi:10.1016/S0223-5234(99)80099-3.
S.K. Srivastava, M. Jaggi, A.T. Singh, A. Madan, N. Rani, M. Vishnoi, S.K. Agarwal, R. Mukherjee and A.C. Burman, Bioorg. Med. Chem. Lett., 17, 6660 (2007); doi:10.1016/j.bmcl.2007.08.006.
D.C. Adelman, M.J. Evanchik, A. Sudhakar, J.W. Jacobs and J.A. Silverman, 1,8-Naphthyridine Compounds for the Treatment of Cancer, US Patent 8124773 B2 (2012).
Y.J. Hwang. Chung, E.C. Nam, W.T. Kim, J.B. Youm and C.H. Leem, Korean J. Physiol. Pharmacol., 17, 537 (2013); doi:10.4196/kjpp.2013.17.6.537.
G. Grover and S.G. Kini, Eur. J. Med. Chem., 41, 256 (2006); doi:10.1016/j.ejmech.2005.09.002.
S.K. Bouchillon, D.J. Hoban, J.L. Johnson, B.M. Johnson, D.L. Butler, K.A. Saunders, L.A. Miller and J.A. Poupard, Int. J. Antimicrob. Agents, 23, 181 (2004); doi:10.1016/j.ijantimicag.2003.08.006.
P.L. Ferrarini, C. Mori, M. Badawneh, V. Calderone, R. Greco, C. Manera, A. Martinelli, P. Nieri and G. Saccomanni, Eur. J. Med. Chem., 35, 815 (2000); doi:10.1016/S0223-5234(00)00173-2.
A. Samadi, C. Valderas, C. Ríos, A. Bastida, M. Chioua, L. González-Lafuente, I. Colmena, L. Gandía, A. Romero, L. Barrio, M.D. Martín-de-Saavedra, M.G. López, M. Villarroya and J. Marco-Contelles, Bioorg. Med. Chem., 19, 122 (2011); doi:10.1016/j.bmc.2010.11.040.
M. Fischer and A. Bacher, Adv. Bot. Res., 58, 93 (2011); doi:10.1016/B978-0-12-386479-6.00003-2.
M. Yaqub, R. Perveen, Z. Shafiq, H. Pervez and M.N. Tahir, Synlett, 1755 (2012); doi:10.1055/s-0031-1289787.
M. Yaqub, C.-Y. Yu, Y.-M. Jia and Z.-T. Huang, Synlett, 1357 (2008); doi:10.1055/s-2008-1072788.
M. Yaqub, N. Arif, R. Perveen, J. Batool, M.T. Riaz and M. Yaseen, Asian J. Chem., 27, 1013 (2015); doi:10.14233/ajchem.2015.18004.